|
Real-time Estimate
Cboe BZX
03:28:57 31/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 42.73 USD | +0.09% |
|
-6.47% | -55.18% |
| 10:37pm | TD Cowen Downgrades Boston Scientific to Hold From Buy Price Target is $46 | MT |
| 30/10 | Stryker Lowers Outlook After 3Q Profit Falls | DJ |
| Market Cap | 61.87B 55.41B 51.12B 46.26B 86.51B 5,891B 87.91B 610B 243B 3,083B 232B 227B 9,766B | P/E 2026 * |
17.2x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 73.71B 66.02B 60.91B 55.12B 103B 7,019B 105B 727B 290B 3,674B 277B 271B 11,635B | EV / Sales 2026 * |
3.52x | EV / Sales 2027 * | 3.31x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
Mexican S.E.
| BSX * | End-of-day quote | |
Tradegate
| BSX | Real-time | |
London S.E.
| 0HOY | Delayed | |
Xetra
| BSX | Delayed | |
Wiener Boerse
| BSXC | End-of-day quote | |
Boerse Muenchen
| BSX | Real-time | |
CBOE
| 0HOY | Real-time | |
Börse Stuttgart
| BSX | Delayed | |
CBOE
| Real-time | ||
Borsa Italiana
| 1BSX | End-of-day quote | |
Deutsche Boerse AG
| BSX | Delayed | |
Swiss Exchange
| BSX | Delayed | |
Swiss Exchange
| BSX | Delayed |
Last Transcript: Boston Scientific Corporation
| 1 day | +0.04% | ||
| 1 week | -6.47% | ||
| Current month | -2.10% | ||
| 1 month | -2.10% | ||
| 3 months | -7.10% | ||
| 6 months | -25.82% | ||
| Current year | -55.18% |
| 1 week | 39.57 | 46.07 | |
| 1 month | 39.57 | 46.16 | |
| Current year | 39.57 | 100.9 | |
| 1 year | 39.57 | 105.65 | |
| 3 years | 39.57 | 109.5 | |
| 5 years | 34.98 | 109.5 | |
| 10 years | 19.67 | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/8/26 | Buy | Director | 2,040 | 0.0001% | ||
| 11/8/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 10/8/26 | Other | Chief Financial Officer | 9,908 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.09% | -6.47% | -57.51% | -14.62% | 61.87B | ||
| -1.47% | +3.03% | +24.82% | +59.93% | 262B | ||
| -2.10% | +0.44% | +7.65% | +25.07% | 167B | ||
| -2.14% | -2.92% | -17.16% | +69.87% | 156B | ||
| -1.21% | +4.82% | +11.84% | +49.72% | 54.44B | ||
| -0.21% | +2.15% | -12.23% | -6.58% | 53.3B | ||
| -3.60% | +0.38% | +21.18% | +71.72% | 51.07B | ||
| +0.69% | -3.34% | +9.55% | +64.09% | 50.25B | ||
| -3.62% | +1.48% | +34.26% | +94.50% | 47.17B | ||
| -17.70% | -11.34% | +141.24% | +121.43% | 43.8B | ||
| Average | -3.15% | +2.28% | +16.37% | +53.51% | 94.64B | |
| Weighted average by Cap. | -2.38% | +2.68% | +11.53% | +51.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 20.96B 18.78B 17.32B 15.68B 29.31B 1,996B 29.79B 207B 82.45B 1,045B 78.68B 77B 3,309B | 21.03B 18.83B 17.38B 15.72B 29.4B 2,002B 29.88B 207B 82.7B 1,048B 78.91B 77.23B 3,319B |
| Net income | 3.6B 3.23B 2.98B 2.69B 5.04B 343B 5.12B 35.51B 14.17B 180B 13.52B 13.23B 569B | 3.41B 3.06B 2.82B 2.55B 4.77B 325B 4.85B 33.64B 13.42B 170B 12.8B 12.53B 539B |
| Net Debt | 11.84B 10.61B 9.79B 8.86B 16.56B 1,128B 16.83B 117B 46.58B 590B 44.44B 43.5B 1,869B | 7.67B 6.87B 6.34B 5.73B 10.72B 730B 10.9B 75.6B 30.16B 382B 28.78B 28.16B 1,210B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/10/26 | USD 42.70 | +0.01% | 7,517,636 |
| 29/10/26 | USD 42.69 | +0.61% | 31,755,378 |
| 28/10/26 | USD 42.43 | -5.84% | 69,837,060 |
| 27/10/26 | USD 45.06 | -1.14% | 15,139,721 |
| 26/10/26 | USD 45.58 | -0.24% | 11,928,715 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions


















